Health care stocks edged higher premarket Monday with the Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) advancing by 0.7% recently.
Tonix Pharmaceuticals Holding (TNXP) shares rose nearly 26% after the company said the US Food and Drug Administration will not require an advisory committee meeting regarding its new drug application for TNX-102 SL, a product candidate to treat fibromyalgia.
Genmab (GMAB) denied Saturday allegations of misappropriating trade secrets related to the use of disaccharides in antibody-drug conjugates in a lawsuit filed by AbbVie (ABBV). Genmab shares were down more than 4% pre-bell.
Novo Nordisk (NVO) shares declined more than 2% after the company said it has agreed to pay up to $2 billion for the exclusive rights for a triple receptor agonist in early-stage clinical development for the treatment of obesity, type 2 diabetes and other diseases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.